Almost 10,000 school staff across Kentucky, Indiana and Ohio have responded to a survey that aims to understand not only what COVID-19 mitigation strategies are being implemented but also how these measures impact staff wellbeing.

The CCTS will host the acclaimed medical historian John M. Barry, author of "The Great Influenza: The Story of the Deadliest Pandemic in History," at the keynote panel of its 2021 Spring Research Days, to be held the afternoons of April 7 and 8.

The CCTS serves as the engine for UK's testing site of the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase 3 clinical research study ENSEMBLE 2, which is evaluating the safety and efficacy of a two-dose regimen of Janssen’s COVID-19 vaccine candidate.

The University of Kentucky, in partnership with Baptist Health Lexington and Norton Healthcare in Louisville, participated as a site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase 3 clinical research study, called the ENSEMBLE trial, to evaluate Janssen’s investigational COVID-19 vaccine candidate.

UK, with partners, has been selected as a testing site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase 3 clinical research study, called the ENSEMBLE trial, to evaluate Janssen’s investigational COVID-19 vaccine candidate. To date, more than 100,000 individuals have been vaccinated with a Janssen AdVac®-based vaccine.

Dr. Lisa Cassis, UK’s vice president for research, oversees the university’s vast medical and nonmedical research efforts. On this episode of "Behind the Blue," she discusses the many areas UK's Office of Research is prioritizing, including greater diversity and inclusion, the increasing commitment to opportunities for undergraduate research, returning research efforts to higher capacity during the COVID-19 pandemic, and more.

The National Science Foundation recently award will support development of new state-of-the-art metabolomics data analysis tools that will derive new data, knowledge and interpretation from the active metabolic state of organisms and ecosystems with broad biological and biomedical applications.

The National Science Foundation recently awarded a three-year, $1,163,869 grant to the University of Kentucky to develop new state-of-the-art metabolomics data analysis tools that will derive new data, knowledge and interpretation from the active metabolic state of organisms and ecosystems with broad biological and biomedical applications.

Jon Thorson and UK were recently awarded a prestigious Centers of Biomedical Research Excellence (COBRE) grant to study translational chemical biology from the National Institutes of General Medical Sciences, part of the National Institutes of Health. The $11.2 million grant will fund UK's Center of Biomedical Research Excellence in Pharmaceutical Research and Innovation.

Through the National COVID Cohort Collaborative, clinical institutions affiliated with the National Institutes of Health’s Clinical and Translational Science Awards Program are partnering with National Center for Advancing Translational Science and the National Center for Data to Health to study COVID-19 and identify potential treatments and analytics tools.